In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus
- 1 August 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (8)
Abstract
Repurposing drugs may be useful as an add-on in the treatment of Mycobacterium abscessus pulmonary infections, which are particularly difficult to cure. M. abscessus naturally produces a β-lactamase, Bla MAb , which is inhibited by avibactam.Keywords
Funding Information
- Association Vaincre la Mucoviscidose (RF20160501637)
This publication has 26 references indexed in Scilit:
- Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung DiseasesJournal of Clinical Microbiology, 2012
- The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous MycobacteriaClinical Microbiology Reviews, 2012
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary DiseaseClinical Infectious Diseases, 2011
- Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl SequencingAntimicrobial Agents and Chemotherapy, 2011
- Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosisJournal of Cystic Fibrosis, 2010
- Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in FranceJournal of Clinical Microbiology, 2009
- Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, IsraelEmerging Infectious Diseases, 2008
- Mycobacterium abscessus and Children with Cystic FibrosisEmerging Infectious Diseases, 2003
- Intraphagocytic penetration of antibioticsJournal of Antimicrobial Chemotherapy, 1988